Request that the FDA conduct a formal scientific and medical evaluation under 21 U.S.C. S811(b) of the currently available evidence regarding N,N-Dimethyltryptamine (DMT), Psilocybin, Lysergic acid diethylamide (LSD), and 3,4-Methylenedioxymethamphetamine (MDMA) | Federal Regulations · Congress.wiki